For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
Lpez-Vicario C, Alcaraz-Quiles J, Garca-Alonso V, Rius B, Hwang S, Titos E, Hwang SH, Lopategi A, Hammock BD, Arroyo V, Clari J (2014) Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides
Measurements of RBF are often indexed to body surface area (BSA) and presented per 1.73 m 2 , thereby providing comparable estimates between different populations
Overview 4.2
IGFBP1 expression is dependent on insulin, which downregulates its production
Thus, the fact that the observed benefits of RETA against PDAC could be indirect by inducing weight loss and improving metabolic parameters - such as blood glucose and insulin - cannot be excluded and need further investigation